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E-mail address: rinayu@ulsan.ac.kr (R. Yu).Obesity-induced adipose tissue inﬂammation is characterized by increased macrophage inﬁltration
and cytokine production, and is associated with metabolic disorders. LIGHT/TNFSF14, a member of
the TNF superfamily, plays a role in the development of various inﬂammatory diseases. The purpose
of this study was to examine the involvement of soluble LIGHT (sLIGHT) in obesity-induced adipose
tissue inﬂammatory responses. LIGHT gene expression on macrophages/adipocytes was upregulated
by treatment with obesity-related factors. sLIGHT displayed chemotactic activity for macrophages
and T cells, and enhanced inﬂammatory cytokine release from macrophages, adipocytes, and adi-
pose tissue-derived SVF cells. The sLIGHT-induced inﬂammatory responses were blunted by neutral-
izing anti-HVEM antibody or knockout of HVEM, a receptor for sLIGHT. These ﬁndings indicate that
sLIGHT enhances adipose tissue inﬂammatory responses through its interaction with HVEM.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Obesity-induced inﬂammation is closely associated with the
development of metabolic complications such as type II diabetes
and atherosclerosis. Recent progress has led to the identiﬁcation
of several adipose tissue inﬂammatory components such as im-
mune cells (e.g. macrophages/T cells) and cytokines/chemokines
that account for obesity-induced inﬂammatory responses and
insulin resistance [1–3]. However, the intrinsic factors that trigger
adipose tissue inﬂammation are not yet completely understood.
LIGHT/TNFSF14 (lymphotoxin-related inducible ligand that
competes for glycoprotein D binding to herpes virus entry media-
tor on T cells) is a member of the TNF superfamily (TNFSF) that
binds to the membrane receptor HVEM/TNFRSF14 (herpes simplex
virus glycoprotein D for herpes virus entry mediator). It is widely
and constitutively expressed in various human and rodent tissues,
and strongly expressed on resting and activated T cells, B cells, and
monocytes [4]. The interaction between LIGHT and its receptor is
involved in various inﬂammatory processes such as inﬂammatory
bowel disease, rheumatoid arthritis and nephritis [5–8]. Recentchemical Societies. Published by E
Food Science and Nutrition,
749, South Korea. Fax: +82 52studies have shown that soluble LIGHT (sLIGHT) promotes athero-
genesis by inducing pro-inﬂammatory cytokines and matrix
metalloproteinases in macrophage/foam cells and endothelial cells
[9]. More recently, involvement of LIGHT (sLIGHT) and HVEM has
been suggested in human obesity and metabolic disorders
[10,11], but the mechanism by which sLIGHT mediates adipose tis-
sue inﬂammatory responses remains elusive.
In this study, we demonstrate that sLIGHT plays a crucial role in
adipose tissue inﬂammatory responses by enhancing macro-
phages/T-cell inﬁltration and activating the cells to release inﬂam-
matory cytokines. The inﬂammatory action of sLIGHT is mediated
by interaction with its receptor HVEM. LIGHT and HVEM are poten-
tial targets for modulating obesity-induced adipose tissue inﬂam-
matory responses.2. Materials and methods
See Supplementary material [19,20].
2.1. Statistical analyses
Data are presented as means ± S.E.M. Statistical analysis was
performed using ANOVA and Duncan’s multiple-range test. Differ-
ences were considered to be signiﬁcant at P < 0.05.lsevier B.V. All rights reserved.
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3.1. LIGHT/HVEM gene expression in macrophages, adipocytes, and
adipose tissue
To test whether LIGHT expression is associated with adipose
tissue inﬂammatory responses in obesity, we treated macro-
phages and adipocytes with obesity-related factors such as free
fatty acid (palmitate), oxidative stress (hydrogen peroxide),
and adipose tissue-conditioned medium. Free fatty acid and
oxidative stress enhanced LIGHT gene expression in 3T3-L1
adipocytes as well as Raw264.7 macrophages (Fig. 1A and B).
Adipose tissue-conditioned medium prepared from obese mice
also upregulated LIGHT gene expression in the macrophages
(Fig. 1B). Expressions of HVEM gene were also stimulated by
free fatty acid and/or adipose tissue-conditioned medium in
adipocytes, macrophages, and adipose tissue-derived SVF cells
(Fig. 1A–C).
We further examined whether the expression of HVEM or
its ligand LIGHT in adipose tissue is altered in obese condition.
C57BL/6 mice were fed a high-fat diet (obese mice) or a regu-
lar diet (lean mice) for 10 weeks, and using RT-PCR analysis
the expression levels of HVEM and LIGHT in the adipose
tissue of the obese and lean mice were measured. LIGHT
mRNA level in adipose tissue was signiﬁcantly higher in the
obese mice than the lean control mice (Fig. 1D), and HVEM
mRNA level was also upregulated in the obese mice
(Fig. 1D). Additionally, we also examined coinhibitory receptors
such as B and T lymphocyte attenuator (BTLA) and CD160 that
bind to HVEM. Interestingly, BTLA mRNA level was signiﬁcantlyFig. 1. Upregulation of LIGHT and/HVEM on macrophages and adipocytes by obesity-r
adipocytes (3T3-L1), and adipose tissue-derived SVF cells were treated with obesity-rela
medium. Free fatty acid (palmitate) was prepared in ethanol containing bovine serum
determined by semiquantitative reverse transcriptase-PCR analysis. 3T3-L1 adipocytes w
levels of 36B4 mRNA. Levels of HVEM or LIGHT mRNA in (B) macrophages or (C) adipos
analysis. Raw 264.7 macrophages were treated with obesity-related factors for 3 h. Levels
independent experiments. Values are means ± S.E.M. ⁄P < 0.05, #P < 0.005, ##P < 0.001 com
in the epididymal adipose tissue of obese and lean mice. Levels of mRNA were estimated
each group. ⁄⁄P < 0.01, #P < 0.005 compared to the lean control.downregulated in the obese adipose tissue, but CD160 was not
(Fig. 1E).
3.2. Chemotactic activities of sLIGHT for T cells and macrophages
Since the accumulation of T cells and macrophages in adipose
tissue is crucial for adipose tissue inﬂammatory responses, we
examined whether sLIGHT can induce macrophage/T cell inﬁltra-
tion. sLIGHT promoted the inﬁltration of Raw 264.7 macrophages
(Fig. 2A) and peritoneal macrophages (Fig. 2B) as well as T cells
(CD4+ and CD8+) (Fig. 2C) in a dose dependent manner. Adipose
tissue-conditioned medium, which induced macrophage and T cell
migration, was signiﬁcantly more effective in inducing cell migra-
tion when sLIGHT was added (Fig. 2D). These ﬁndings suggest that
adipose-derived sLIGHT may play a role in enhancing macrophage/
T cell inﬁltration, and thus participate in adipose tissue inﬂamma-
tory responses.
3.3. Effect of sLIGHT on cytokine/chemokine production by
macrophages and adipocytes
To examine the effect of sLIGHT on inﬂammatory cytokine re-
lease from adipose cells, macrophages (Raw 264.7) and adipocytes
(3T3-L1) were treated with sLIGHT and cytokine release was mea-
sured. sLIGHT treatment increased TNFa and IL-6 release from
macrophages (Fig. 2E), MCP-1 and IL-6 from adipocytes (Fig. 2F),
and MCP-1 and IL-6 from adipose tissue-derived SVF cells
(Fig. 2G). This indicates that adipose tissue-derived sLIGHT may
enhance inﬂammatory responses in obesity in an autocrine and/
or paracrine manner.elated factors and adipose tissue-conditioned medium. Macrophages (Raw 264.7),
ted factors (H2O2 50 lM, free fatty acid 500 lM) and/or adipose tissue-conditioned
albumin (BSA, 50 lM). (A) LIGHT mRNA expression levels in adipocytes (3T3-L1)
ere treated with obesity-related factors for 24 h. Levels of mRNA were normalized to
e tissue-derived SVF cells were measured by a real-time reverse transcriptase-PCR
of mRNA were normalized to levels of b-actin mRNA. Data represent results of three
pared to untreated control. Levels of (D) LIGHT, HVEM, (E) BTLA, and CD160 mRNAs
by real-time reverse transcriptase-PCR. Data are means ± S.E.M. of four animals for
Fig. 2. sLIGHT-induced inﬂammatory responses of macrophages/T cells. Chemotactic activity was measured using a Boyden chamber. (A) Raw 264.7 macrophages (B)
peritoneal MQs and (C) T cells (CD4+ and CD8+) were incubated for 3 h with sLIGHT (0, 100, and 300 ng/ml) and adipose tissue-conditioned medium (ATCM). (D) Macrophage
(Raw 264.7) migration was induced by adipose tissue-conditioned medium (ATCM) containing sLIGHT (100 and 300 ng/ml). Cytokine concentrations in supernatants were
determined by ELISA. (E) Raw 264.7 macrophages were incubated with 0, 100, and 300 ng/ml of sLIGHT for 18 h. (F) Mature 3T3-L1 adipocytes were incubated with 0, and
500 ng/ml of sLIGHT for 24 h. (G) Adipose tissue-derived SVF cells were incubated with 0, 100, and 300 ng/ml of sLIGHT for 18 h. Data represent results of three independent
experiments. Values are means ± S.E.M. ⁄P < 0.05, #P < 0.005, ##P < 0.001 compared to untreated control.
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inﬂammatory responses
In order to test whether the sLIGHT-induced inﬂammatory ef-
fects are mediated by its receptor, HVEM, we examined the effect
of neutralizing antibody against HVEM. As shown in Fig. 3A,
sLIGHT-induced chemotactic activity for macrophages was blunted
by exposure to anti-HVEM antibody. The chemotactic activity for
macrophages induced by adipose tissue-conditioned medium
was also inhibited by anti-HVEM antibody (Fig. 3B). We also exam-
ined the effect of HVEM deﬁciency on macrophages and T cells
migration. As shown in Fig. 3C and D, sLIGHT-induced migration
was markedly reduced in HVEM-deﬁcient macrophages as well
as T cells (CD4+ and CD8+). Moreover, sLIGHT-induced cytokine re-
lease (MCP-1 and IL-6) from adipose tissue-derived SVF cells was
also markedly reduced (Fig. 3E and F). We also observed that
MCP-1 and IL-6 production was impaired in HVEM-deﬁcient SVF
cells without sLIGHT treatment, and this may imply a role of HVEM
in maintaining non-adipose cells homeostasis.
3.5. Cytokine release from adipocytes co-cultured with HVEM-deﬁcient
adipose tissue-derived SVF cells
When we co-cultured adipocytes with the adipose tissue-
derived SVF cells from HVEM-deﬁcient mice and wild type mice,the release of IL-6 and MCP-1 from the SVF cells was signiﬁcantly
lower in the case of the HVEM-deﬁcient mice than in that of the
wild type mice (Fig. 4A and B), indicating that adipocyte-derived
LIGHT cannot act on SVF cells to cause release of cytokines in the
absence of HVEM. These ﬁndings together strongly suggest that
the LIGHT-induced inﬂammatory effects (e.g. chemotaxis and cyto-
kine release) in adipose tissue are mediated by its interaction with
HVEM.4. Discussion
The present study demonstrates that the interaction between
sLIGHT and HVEM contributes to adipose tissue inﬂammation by
enhancing T cell/macrophage accumulation and activation, so cre-
ating a vicious inﬂammatory cycle.
The interaction between LIGHT and HVEM provides a pro-
inﬂammatory signal to T cells and macrophages to produce
inﬂammatory responses such as cytokine release, cell growth and
survival [12–14]. Recent reports have shown that serum levels of
sLIGHT increase in obese patients [11], and, moreover, sLIGHT
increases release of inﬂammatory cytokines/chemokines from
human adipocytes [11], suggesting a pathogenic potential for
sLIGHT in obesity-induced inﬂammation. With regard to the cellu-
lar target of sLIGHT in adipose tissue inﬂammation, there are three
Fig. 3. Effect of anti-HVEM antibody and HVEM deﬁciency on sLIGHT-induced inﬂammatory responses. Macrophage were placed in the upper wells of a 96-well culture
chamber separated from the lower wells containing sLIGHT or adipose tissue-conditioned medium, in the presence or absence of anti-HVEM mAb (1 and 3 lg/ml), and
incubated for 3 h at 37 C. Chemotactic activities of (A) Raw 264.7 cells and (B) peritoneal macrophages treated with anti-HVEM Ab. (C) Chemotactic activities of HVEM-
deﬁcient peritoneal macrophages (D) and T cells (CD4+ and CD8+) treated with sLIGHT. (E) sLIGHT-induced cytokine release. Adipose tissue-derived SVF cells isolated from
HVEM-deﬁcient mice were treated with sLIGHT for 18 h. Cytokine concentrations in the supernatant were determined by ELISA. Data represent results of three independent
experiments. Values are means ± S.E.M. ⁄P < 0.05, ⁄⁄P < 0.01, #P < 0.005, ##P < 0.001 compared to untreated control.
Fig. 4. Cytokine release from adipocytes co-cultured with HVEM-deﬁcient adipose
tissue-derived SVF cells. 3T3-L1 adipocytes (3  105 cells) were cultured in 24 well
plates with or without adipose tissue-derived SVF cells (3  104 cells) from HVEM-
deﬁcient (KO) or wild type (WT) mice for 3, 6, and 12 h. (A) MCP-1 and (B) IL-6
cytokine concentrations in the supernatant were determined by ELISA. Data
represent results of three independent experiments. Values are means ± S.E.M.
⁄P < 0.05, ⁄⁄P < 0.01, #P < 0.005, ##P < 0.001 compared to 3T3-L1 adipocytes or 3T3-
L1 adipocytes co-cultured with SVF cells from wild type mice.
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and T cells. Thus, it was worth examining whether sLIGHT is
involved in the crosstalk between T cells/macrophages and adipo-
cytes that is crucial for adipose tissue inﬂammation. We observed
ﬁrst that LIGHT expression in macrophages and adipocytes was
upregulated by obesity-related factors such as free fatty acid and
oxidative stress. Continuously, we found that LIGHT and HVEM
mRNA levels in adipose tissue were upregulated in obese mice, fur-
ther underscoring the potential role of LIGHT in obesity-related
adipose tissue inﬂammation. Given that sLIGHT enhances inﬂam-
matory responses in human monocytes [15], we hypothesized that
the increase of sLIGHT in adipose tissue might stimulate adipose
tissue macrophage recruitment and activation. Indeed, we found
that sLIGHT had chemotactic activity for murine Raw 264.7 macro-phages and peritoneal macrophages, and subsequently found that
it can also induce T cells (CD4+ and CD8+) migration, indicating
that sLIGHT could be a chemotactic factor released by adipose tis-
sue enhancing macrophages/T cells accumulation. Moreover, we
found that sLIGHT strongly stimulated release of inﬂammatory
cytokines/chemokines (e.g. TNFa, IL-6, and MCP-1) from macro-
phages, adipocytes, and adipose tissue-derived SVF cells. Taken to-
gether, these ﬁndings suggest that sLIGHT released from adipose
cells acts as a potent inducer of obesity-mediated adipose tissue
inﬂammatory responses by recruiting T cell/macrophage into in-
ﬂamed tissues and activating them, so aggravating adipose tissue
inﬂammation (Fig. 5).
LIGHT binds to three distinct receptors: HVEM, lymphotoxin
beta receptor, and decoy receptor 3; these are expressed on a vari-
ety of cell types, with the result that LIGHT elicits multiple cellular
activities [16]. Upon binding to HVEM, it stimulates T cells/macro-
phages and accelerates their proliferation and cytokine production.
Interestingly, it has been shown recently that HVEM, which is con-
stitutively expressed on T cells and monocytes/macrophages [4], is
markedly elevated in the adipose tissue of obese patients, and its
expression is higher in visceral adipose tissue than in subcutane-
ous tissue [10]. HVEM expression has also been detected in mature
human adipocytes and adipose tissue-derived SVF cells [10].
Although a role of the interaction of LIGHT with HVEM and other
receptors in various inﬂammatory diseases has been suggested,
the pathogenic effects and underlying mechanism in obesity-
induced inﬂammation have not been fully explored. In view of the
previously reported expression of LIGHT in adipose tissue [11]
and the upregulation of HVEM and LIGHT by obesity-related fac-
tors observed by us, it seemed likely that LIGHT mediates adipose
tissue inﬂammatory responses through HVEM. Indeed, treatment
with neutralizing anti-HVEM antibody markedly blunted the inﬁl-
tration of CD4+ or CD8+ T cells/macrophages and the release of
cytokines induced by sLIGHT and adipose tissue-conditioned med-
Fig. 5. Schematic presentation for the effect of sLIGHT adipose tissue inﬂammation. sLIGHT released from adipose cells acts as a potent inducer of obesity-mediated adipose
tissue inﬂammatory responses by recruiting T cell/macrophage into inﬂamed tissues and activating them, so aggravating adipose tissue inﬂammation.
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sLIGHT-induced migration of T cells/and macrophages and their
cytokine production. These ﬁndings strongly support the idea that
sLIGHT and HVEM interaction is important in promoting inﬂam-
matory responses in obese adipose tissue.
Additionally, it has been shown that HVEM can bind to coinhib-
itory receptors BTLA and/or CD160 [17]. The coinhibitory receptors
transmit inhibitory signals bidirectionally, which complicates
HVEM-mediated network [17]. However, it is likely that HVEM
can simultaneously transmit inﬂammatory signal by activating
NF-kB [18]. Blocking HVEM would then disrupt both costimula-
tory/coinhibitory signals. With respect this, we found that levels
of LIGHT mRNA in adipose tissue was signiﬁcantly increased in ob-
ese mice compared with lean control, whereas BTLA expression
was markedly reduced, indicating that BTLA-mediated coinhibitory
signal may be suppressed in obese conditions. Further study is
needed to clarify how HVEM and its binding partners differentially
participate in adipose tissue inﬂammation.
Taken together, these ﬁndings suggest that the HVEM/LIGHT
interaction is important in promoting leukocyte inﬁltration/activa-
tion in obese adipose tissue, and that blocking HVEM or LIGHT may
be useful for disrupting the pathogenic loop causing adipose tissue
inﬂammation in obesity.
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